These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 25006881)

  • 21. Gut microbiota: A new piece in understanding hepatocarcinogenesis.
    Zhou A; Tang L; Zeng S; Lei Y; Yang S; Tang B
    Cancer Lett; 2020 Apr; 474():15-22. PubMed ID: 31917160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can non-selective beta-blockers prevent hepatocellular carcinoma in patients with cirrhosis?
    Thiele M; Wiest R; Gluud LL; Albillos A; Krag A
    Med Hypotheses; 2013 Nov; 81(5):871-4. PubMed ID: 24060485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of the intestinal microbiome in liver disease.
    Henao-Mejia J; Elinav E; Thaiss CA; Licona-Limon P; Flavell RA
    J Autoimmun; 2013 Oct; 46():66-73. PubMed ID: 24075647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [H.pylori in patients with cirrhosis and liver cirrhosis with hepatocellular carcinoma].
    Xu MH; Qu Q; Zhang GY
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Oct; 32(5):917-20. PubMed ID: 18007096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intestinal microbiota in patients with chronic hepatitis C with and without cirrhosis compared with healthy controls.
    Heidrich B; Vital M; Plumeier I; Döscher N; Kahl S; Kirschner J; Ziegert S; Solbach P; Lenzen H; Potthoff A; Manns MP; Wedemeyer H; Pieper DH
    Liver Int; 2018 Jan; 38(1):50-58. PubMed ID: 28561276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatocellular Carcinoma Immunotherapy and the Potential Influence of Gut Microbiome.
    Temraz S; Nassar F; Kreidieh F; Mukherji D; Shamseddine A; Nasr R
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gut microbiota and liver disease.
    Goel A; Gupta M; Aggarwal R
    J Gastroenterol Hepatol; 2014 Jun; 29(6):1139-48. PubMed ID: 24547986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microbiota and gastrointestinal cancer.
    Weng MT; Chiu YT; Wei PY; Chiang CW; Fang HL; Wei SC
    J Formos Med Assoc; 2019 Mar; 118 Suppl 1():S32-S41. PubMed ID: 30655033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection.
    Attallah AM; Shiha GE; Ismail H; Mansy SE; El-Sherbiny R; El-Dosoky I
    Clin Biochem; 2009 Apr; 42(6):455-61. PubMed ID: 19063876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular events in the pathogenesis of hepadnavirus-associated hepatocellular carcinoma.
    Robinson WS
    Annu Rev Med; 1994; 45():297-323. PubMed ID: 8198385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gut microbiota and hepatitis-B-virus-induced chronic liver disease: implications for faecal microbiota transplantation therapy.
    Kang Y; Cai Y
    J Hosp Infect; 2017 Aug; 96(4):342-348. PubMed ID: 28545829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatocellular Cancer and Gut Microbiome: Time to Untie Gordian's Knot.
    Aygün C; Tözün N
    J Gastrointest Cancer; 2021 Dec; 52(4):1309-1313. PubMed ID: 34750696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver cell dysplasia in liver cirrhosis and hepatocellular carcinoma.
    Szczepański W
    Pol J Pathol; 1997; 48(3):147-57. PubMed ID: 9401407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis B virus, hepatocellular carcinoma and liver cirrhosis in Kenya.
    Mwangi J; Gatei DG
    East Afr Med J; 1993 Apr; 70(4 Suppl):34-6. PubMed ID: 8223308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The gut microbiome and liver cancer: mechanisms and clinical translation.
    Yu LX; Schwabe RF
    Nat Rev Gastroenterol Hepatol; 2017 Sep; 14(9):527-539. PubMed ID: 28676707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
    Yeh MM; Larson AM; Campbell JS; Fausto N; Rulyak SJ; Swanson PE
    Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of the Hedgehog pathway in hepatocellular carcinoma (review).
    Zheng X; Zeng W; Gai X; Xu Q; Li C; Liang Z; Tuo H; Liu Q
    Oncol Rep; 2013 Nov; 30(5):2020-6. PubMed ID: 23970376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gut Microbiota Promotes Obesity-Associated Liver Cancer through PGE
    Loo TM; Kamachi F; Watanabe Y; Yoshimoto S; Kanda H; Arai Y; Nakajima-Takagi Y; Iwama A; Koga T; Sugimoto Y; Ozawa T; Nakamura M; Kumagai M; Watashi K; Taketo MM; Aoki T; Narumiya S; Oshima M; Arita M; Hara E; Ohtani N
    Cancer Discov; 2017 May; 7(5):522-538. PubMed ID: 28202625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Strategies for the prevention of hepatocellular carcinoma in the context of chronic viral hepatitis].
    Schott E; Bergk A; Berg T
    Z Gastroenterol; 2008 Jan; 46(1):69-80. PubMed ID: 18188819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology of hepatocellular carcinoma. Evaluation of viral and other risk factors in a low-endemic area for hepatitis B and C.
    Peters M; Wellek S; Dienes HP; Junginger T; Meyer J; Meyer Zum Büschendfelde KH; Gerken G
    Z Gastroenterol; 1994 Mar; 32(3):146-51. PubMed ID: 8197809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.